BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 36198881)

  • 1. [Diagnostics and treatment of intraductal papillary mucinous pancreas neoplasm].
    Khatkov IE; Poroshina EG; Solovyeva OI; Tokareva TP; Vorobyev SL; Bakulina NV
    Ter Arkh; 2023 Oct; 95(8):686-691. PubMed ID: 38158906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraductal Papillary Mucinous Neoplasms in High-Risk Individuals: Incidence, Growth Rate, and Malignancy Risk.
    Overbeek KA; Koopmann BDM; Levink IJM; Tacelli M; Erler NS; Arcidiacono PG; Ausems MGE; Wagner A; van Eijck CH; Groot Koerkamp B; Busch OR; Besselink MG; van der Vlugt M; van Driel LMJW; Fockens P; Vleggaar FP; Poley JW; Capurso G; Cahen DL; Bruno MJ;
    Clin Gastroenterol Hepatol; 2024 Jan; 22(1):62-71.e7. PubMed ID: 37031711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute pancreatitis in intraductal papillary mucinous neoplasm: a single-center retrospective cohort study with systematic review and meta-analysis.
    Xu JH; Ni CY; Zhuang YY; Li L; Lin Y; Xia ZS; Wu WR; Chen QK; Zhong W
    BMC Gastroenterol; 2023 Dec; 23(1):424. PubMed ID: 38041073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of adjuvant therapy in patients with invasive intraductal papillary mucinous neoplasms of the pancreas: an international multicenter cohort study.
    Choi M; Wang SE; Park JS; Kim HS; Choi SH; Lee JH; Chong JU; Nagakawa Y; Wada K; Nakamura Y; Sunagawa H; Dasari BV; Peng CM; Seng LL; Wolters H; Gurbadam U; Park BU; Winslow E; Fishbein T; Hawksworth J; Radkani P; Kang CM
    Int J Surg; 2023 Oct; 109(10):2906-2913. PubMed ID: 37300881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal surveillance of intraductal papillary mucinous neoplasms of the pancreas focusing on remnant pancreas recurrence after surgical resection.
    Fuji T; Umeda Y; Takagi K; Yoshida R; Yoshida K; Yasui K; Matsumoto K; Kato H; Yagi T; Fujiwara T
    BMC Cancer; 2022 May; 22(1):588. PubMed ID: 35643422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The combination of eyeMax direct visualization system, EUS and ERCP for the precise treatment of intraductal papillary mucinous neoplasm.
    Zhang W; Hou SL; Tian J; Zhang LC
    Rev Esp Enferm Dig; 2023 Dec; 115(12):740-741. PubMed ID: 38031912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastrointestinal cancer precursor risk and mortality in pancreatic intraductal papillary mucinous neoplasms: a nationwide cohort study.
    Vujasinovic M; Elbe P; Ekheden I; Wang QL; Thuresson M; Roelstraete B; Ghazi S; Löhr JM; Ludvigsson JF
    Scand J Gastroenterol; 2024 May; 59(5):600-607. PubMed ID: 38351653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic Syndrome Accelerates the Age-Related Increase of Intraductal Papillary Mucinous Neoplasm of the Pancreas.
    Tanaka S; Tsujimae M; Masuda A; Inoue J; Inomata N; Uemura H; Kohashi S; Nagao K; Masuda S; Abe S; Gonda M; Yamakawa K; Ashina S; Nakano R; Tanaka T; Yamada Y; Sakai A; Kobayashi T; Shiomi H; Fujita K; Anami T; Fujita T; Watanabe A; Kodama Y
    Pancreas; 2024 Jan; 53(1):e9-e15. PubMed ID: 37890158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peak density of immature nerve cells occurs with high-grade dysplasia in intraductal papillary mucinous neoplasms of the pancreas.
    Trinh VQ; Roland JT; Wong J; Revetta F; Patel K; Shi C; DelGiorno KE; Carter BD; Tan MCB
    J Pathol; 2022 Sep; 258(1):69-82. PubMed ID: 35686747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk Perceptions and Risk Thresholds Among Surgeons in the Management of Intraductal Papillary Mucinous Neoplasms.
    Sacks GD; Shin P; Braithwaite RS; Soares KC; Kingham TP; D'Angelica MI; Drebin JA; Jarnagin WR; Wei AC
    Ann Surg; 2023 Nov; 278(5):e1073-e1079. PubMed ID: 37796751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Influence of Patient Preference on Surgeons' Treatment Recommendations in the Management of Intraductal Papillary Mucinous Neoplasms.
    Sacks GD; Shin P; Braithwaite RS; Soares KC; Kingham TP; D'Angelica MI; Drebin JA; Jarnagin WR; Wei AC
    Ann Surg; 2023 Nov; 278(5):e1068-e1072. PubMed ID: 36804447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential spatial distribution of HNF4α isoforms during dysplastic progression of intraductal papillary mucinous neoplasms of the pancreas.
    Wong J; Trinh VQ; Jyotsana N; Baig JF; Revetta F; Shi C; Means AL; DelGiorno KE; Tan M
    Sci Rep; 2023 Nov; 13(1):20088. PubMed ID: 37974020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utilization of texture features of volumetric ADC maps in differentiating between serous cystadenoma and intraductal papillary neoplasms.
    Ansari G; Mirza-Aghazadeh-Attari M; Afyouni S; Mohseni A; Shahbazian H; Kamel IR
    Abdom Radiol (NY); 2024 Apr; 49(4):1175-1184. PubMed ID: 38378839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Burgeoning rise in intraductal papillary mucinous neoplasia (IPMN) - a blessing in disguise.
    Søreide K
    Scand J Gastroenterol; 2023; 58(9):1101-1104. PubMed ID: 37022179
    [No Abstract]   [Full Text] [Related]  

  • 15. The Surveillance for Presumed BD-IPMN of the Pancreas.
    Deng H; Dou W; Pan Y
    Gastroenterology; 2024 May; 166(5):939-940. PubMed ID: 37549750
    [No Abstract]   [Full Text] [Related]  

  • 16. Streamlining IPMN follow-up: Embracing a standardized and abbreviated MRI protocol.
    Brandi N; Renzulli M
    Pancreatology; 2024 May; 24(3):498-499. PubMed ID: 38519395
    [No Abstract]   [Full Text] [Related]  

  • 17. S6 ribosomal protein phosphorylation is associated with malignancy of intraductal papillary mucinous neoplasm of the pancreas.
    Hirashita T; Hirashita Y; Iwashita Y; Endo Y; Kiyonaga M; Matsumoto S; Hijiya N; Moriyama M; Murakami K; Inomata M
    Ann Gastroenterol Surg; 2020 Sep; 4(5):571-579. PubMed ID: 33005852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraductal papillary mucinous neoplasms of the pancreas: Uncommon imaging presentation, evolution and comparison of guidelines.
    Minelli C; Balducci F; Cavalleri C; Milanetto AC; Ferrara F; Crimì F; Quaia E; Vernuccio F
    Eur J Radiol Open; 2023 Dec; 11():100531. PubMed ID: 37920680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A scoring system for predicting malignancy in intraductal papillary mucinous neoplasms of the pancreas: a multicenter EUROPEAN validation.
    Manuel-Vázquez A; Balakrishnan A; Agami P; Andersson B; Berrevoet F; Besselink MG; Boggi U; Caputo D; Carabias A; Carrion-Alvarez L; Franco CC; Coppola A; Dasari BVM; Diaz-Mercedes S; Feretis M; Fondevila C; Fusai GK; Garcea G; Gonzabay V; Bravo MÁG; Gorris M; Hendrikx B; Hidalgo-Salinas C; Kadam P; Karavias D; Kauffmann E; Kourdouli A; La Vaccara V; van Laarhoven S; Leighton J; Liem MSL; Machairas N; Magouliotis D; Mahmoud A; Marino MV; Massani M; Requena PM; Mentor K; Napoli N; Nijhuis JHT; Nikov A; Nistri C; Nunes V; Ruiz EO; Pandanaboyana S; Saborido BP; Pohnán R; Popa M; Pérez BS; Bueno FS; Serrablo A; Serradilla-Martín M; Skipworth JRA; Soreide K; Symeonidis D; Zacharoulis D; Zelga P; Aliseda D; Santiago MJC; Mancilla CF; Fragua RL; Hughes DL; Llorente CP; Lesurtel M; Gallagher T; Ramia JM;
    Langenbecks Arch Surg; 2022 Dec; 407(8):3447-3455. PubMed ID: 36198881
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.